Vivani Medical Inc VANI
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-12-05 |
| Shares Out. | 86,240,000 |
| Website | vivani.com/ ↗ |
| Phone | 18887057274 |
| Employees | 36 |
| Net Income | -$6.8M |
| Free Cash Flow | -$26.5M |
| Total Assets | $42.4M |
| Total Liabilities | $23.3M |
| Equity | $19.1M |
About Vivani Medical Inc
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Vivani Medical Inc is a publicly traded company under the ticker symbol VANI on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)